2010
DOI: 10.1007/s11845-010-0641-9
|View full text |Cite
|
Sign up to set email alerts
|

The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism

Abstract: Sestamibi scintigraphy was more likely to be positive in younger patients without nodular thyroid disease who have larger parathyroid adenomas with more severe hyperparathyroidism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 17 publications
0
12
0
Order By: Relevance
“…Thirteen studies were prospective [10][11][12][16][17][18][19][20][21][22][23][24][25] and 15 were retrospective. 4,5,[26][27][28][29][30][31][32][33][34][35][36][37][38] Levels of evidence analysis were determined to be level III (cohort studies) and V (case series). The main concerns regarding study quality were: minor variations in patient inclusion criteria, potential bias in patient selection inherent to retrospective studies, and heterogeneity in the reporting of data and summary statistics.…”
Section: Quality Of Included Studiesmentioning
confidence: 99%
See 2 more Smart Citations
“…Thirteen studies were prospective [10][11][12][16][17][18][19][20][21][22][23][24][25] and 15 were retrospective. 4,5,[26][27][28][29][30][31][32][33][34][35][36][37][38] Levels of evidence analysis were determined to be level III (cohort studies) and V (case series). The main concerns regarding study quality were: minor variations in patient inclusion criteria, potential bias in patient selection inherent to retrospective studies, and heterogeneity in the reporting of data and summary statistics.…”
Section: Quality Of Included Studiesmentioning
confidence: 99%
“…4,5,[10][11][12]17,19,20,22,23,30,31 Dual-phase 99m Tc-sestamibi (MIBI) was assessed in 13 studies. 4,10,11,[19][20][21]24,[28][29][30]32,37,38 Based on 11 studies, 4,10,11,19,20,22,24,28,31,32,38 MIBI had a pooled sensitivity of 0.76 (95% CI 0.71-0.80) and PPV of 0.86 (95% CI 0.82-0.90). Interestingly, some of these studies (n 5 10) also included comparative cohorts without concurrent thyroid pathology showing sensitivity of MIBI ranging from 0.63 to 1.00 and PPV from 0.92 to 1.00.…”
Section: Imaging Modalitiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Approximately 80% of cases of this disease are a result of a solitary parathyroid adenoma. The success rate in surgical treatment is high on condition that localisation diagnostics are accurate [1].…”
Section: Maria Henryka Listewnik Et Al Semi-quantitative Parathyroimentioning
confidence: 99%
“…Reported sensitivity of planar scintigraphy is 69-90 % (16,17,18,19) with the positive predictive value 97.8 % in patients without thyroid pathology (10). SPECT is a more advanced method with sensitivity 78.9-96 % and the positive predictive value 90.7 % (12,13,20).…”
mentioning
confidence: 99%